[HTML][HTML] Development and evaluation of [64Cu] Cu-DOTATATE for clinical applications
S Zolghadri, F Badipa, N Amraee… - Iranian Journal of …, 2023 - irjnm.tums.ac.ir
Introduction: Peptide-based radiopharmaceuticals have great advantages that make them
one of the most interesting radiotracers for theranostic applications. This study aims to …
one of the most interesting radiotracers for theranostic applications. This study aims to …
Optimized Production of 188Re-HYNIC-Bombesin: New Therapeutic Agent for GRPR Targeting
S Vosoughi, N Salek, S Zolghadri… - Nuclear Medicine and …, 2024 - Springer
Purpose One of the most interesting methods to deliver therapeutic doses of ionizing
radiation to tumor sites is radiolabeled compounds. Bombesin peptide binds to gastrin …
radiation to tumor sites is radiolabeled compounds. Bombesin peptide binds to gastrin …
Preparation, quality control, biological evaluation, and human absorbed dose estimation of 188Re-HYNIC-TOC
S Shokri, F Johari-Daha, SMR Aghamiri… - Radiochimica …, 2022 - degruyter.com
In this study, concerning the advantages of rhenium-188 over other therapeutic
radionuclides, such as its stock availability from 188W/188Re generator and radiolabeled …
radionuclides, such as its stock availability from 188W/188Re generator and radiolabeled …
[PDF][PDF] Estimation of human absorbed dose using compartmental model
M Mousavi-Daramoroudi, H Yousefnia… - imaging (ie, 111In …, 2018 - researchgate.net
Dosimetry is an indispensable and precious factor in patient treatment planning to minimize
the absorbed dose in vital tissues. In this study, compartmental model was used in order to …
the absorbed dose in vital tissues. In this study, compartmental model was used in order to …
Evaluation of the produced 177Lu-specific activity via direct and indirect methods using Tehran Research Reactor
S Shirvani Arani, A Bahrami-Samani… - Journal of Nuclear …, 2023 - jonsat.nstri.ir
The present research investigates the feasibility of producing the radionuclide Lutetium-177
(177Lu) at the Tehran research reactor, TRR. 177Lu, with suitable nuclear decay …
(177Lu) at the Tehran research reactor, TRR. 177Lu, with suitable nuclear decay …
Optimized production, quality control and biodistribution assessment of 166Ho–DOTATOC: a novel radiolabelled somatostatin analog
A Golabi-dezfoli, H Yousefnia, M Hosntalab… - … of Radioanalytical and …, 2017 - Springer
Nowadays, peptide receptor radionuclide therapy is used to treat a specific type of cancer
called neuroendocrine tumors. In this research, the optimized conditions for 166 Ho …
called neuroendocrine tumors. In this research, the optimized conditions for 166 Ho …
[PDF][PDF] Biodistribution Studies of 177Lu-DOTATOC in Mouse Tumor Model: Possible Utilization in Adenocarcinoma Breast Cancer Treatment
M Mousavi-Daramoroudi, H Yousefnia… - … Journal of Medical …, 2018 - researchgate.net
DOTATOC, to our best Nnowledge, the therapeutic benefit of 177Lu-DOTATOC complex in
breast cancer has not been reported until now. In this study, biodistribution of 177Lu-DOTA …
breast cancer has not been reported until now. In this study, biodistribution of 177Lu-DOTA …
[引用][C] Absorbed Dose Estimation of 177Lu-DOTATOC in Adenocarcinoma Breast Cancer Bearing Mice
S Zolghadri, M Mousavi-Daramoroudi, H Yousefnia… - International Journal of …, 2018
[引用][C] Time Dependent Biodistribution Modeling of 177Lu-DOTATOC Using Compartmental Analysis
M Mousavi-Daramoroudi, H Yousefnia… - International Journal of …, 2018
[引用][C] International Journal of Medical, Medicine and Health Sciences
S Zolghadri, M Mousavi-Daramoroudi, H Yousefnia…